Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001104659-19-035057

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schmidt Keith · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +50,000 $5.25 2029-06-11 50,000 50,000 D
Loading xslF345X03/a4.xml…